BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20925965)

  • 21. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic value of multislice spiral CT and MRI in detection of tumor recurrence after liver transplantation for hepatocellular carcinoma].
    Wang J; He BJ; Jiang ZB; Zhang YQ; Shan H; Xiao R; Zhang JS; Luo L; Kuang SC; Chen GH; Yang Y
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):691-6. PubMed ID: 20021867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prognosis of hepatocellular carcinoma: a study of 832 cases].
    Yan T; Zhao JJ; Bi XY; Zhao H; Huang Z; Li ZY; Zhou JG; Li Y; Li C; Cai JQ; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):54-8. PubMed ID: 23648302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.
    Feng J; Zhu R; Chang C; Yu L; Cao F; Zhu G; Chen F; Xia H; Lv F; Zhang S; Sun L
    PLoS One; 2016; 11(3):e0151501. PubMed ID: 26977595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical and oncological outcomes of hepatic resection for BCLC-B hepatocellular carcinoma: a retrospective multicenter analysis among 474 consecutive cases.
    Di Sandro S; Centonze L; Pinotti E; Lauterio A; De Carlis R; Romano F; Gianotti L; De Carlis L;
    Updates Surg; 2019 Jun; 71(2):285-293. PubMed ID: 30941704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of hepatocellular carcinoma recurrence after liver transplantation: perioperative prognostic factors, patterns, and outcome.
    Chan KM; Chou HS; Wu TJ; Lee CF; Yu MC; Lee WC
    Asian J Surg; 2011 Jul; 34(3):128-34. PubMed ID: 22208688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.
    Yao FY; Ferrell L; Bass NM; Watson JJ; Bacchetti P; Venook A; Ascher NL; Roberts JP
    Hepatology; 2001 Jun; 33(6):1394-403. PubMed ID: 11391528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.
    Lemekhova A; Hornuss D; Polychronidis G; Mayer P; Rupp C; Longerich T; Weiss KH; Büchler M; Mehrabi A; Hoffmann K
    World J Surg Oncol; 2020 May; 18(1):93. PubMed ID: 32397993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prognostic value of a classification system for centrally located liver tumors in the setting of hepatocellular carcinoma after mesohepatectomy.
    Qiu J; Chen S; Wu H; Du C
    Surg Oncol; 2016 Dec; 25(4):441-447. PubMed ID: 26987943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.
    Nanashima A; Sumida Y; Abo T; Shindou H; Fukuoka H; Takeshita H; Hidaka S; Tanaka K; Sawai T; Yasutake T; Nagayasu T; Omagari K; Mine M
    J Gastroenterol; 2006 Mar; 41(3):250-6. PubMed ID: 16699859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population.
    Cucchetti A; Piscaglia F; Caturelli E; Benvegnù L; Vivarelli M; Ercolani G; Cescon M; Ravaioli M; Grazi GL; Bolondi L; Pinna AD
    Ann Surg Oncol; 2009 Feb; 16(2):413-22. PubMed ID: 19034578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
    Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria.
    Cho Y; Lee JH; Lee DH; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS
    Oncotarget; 2017 Jul; 8(29):47555-47564. PubMed ID: 28548930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
    Minagawa M; Ikai I; Matsuyama Y; Yamaoka Y; Makuuchi M
    Ann Surg; 2007 Jun; 245(6):909-22. PubMed ID: 17522517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis.
    Xie QS; Chen ZX; Zhao YJ; Gu H; Geng XP; Liu FB
    Asian J Surg; 2021 Jan; 44(1):36-45. PubMed ID: 32988708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma.
    Kato H; Yoshida H; Taniguch H; Nomura R; Sato K; Suzuki I; Nakata R
    World J Gastroenterol; 2015 Dec; 21(46):13101-12. PubMed ID: 26673627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simplified staging for hepatocellular carcinoma.
    Vauthey JN; Lauwers GY; Esnaola NF; Do KA; Belghiti J; Mirza N; Curley SA; Ellis LM; Regimbeau JM; Rashid A; Cleary KR; Nagorney DM
    J Clin Oncol; 2002 Mar; 20(6):1527-36. PubMed ID: 11896101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.